A. Boettcher, F. W. Lichtenthaler / Tetrahedron: Asymmetry 15 (2004) 2693–2701
2699
(c 1.4, CHCl3). 1H NMR (300MHz, CDCl3): d 4.42
(ddd, 1H, H-2a), 4.49 (dd, 1H, H-2b), 5.69 (ddd, 1H,
H-3), 6.00 (dd, 1H, H-5), 6.07 (ddd, 1H, H-4), 7.20–
7.99 (m, 10H, 2C6H5), 9.30 (s, 1H, CHO); J2,2 = 11.8,
J2,3 = 3.0 and 6.5, J2b,4 = 1.2, J3,4 = 4.0, J3,5 = 0.5,
J4,5 = 3.8Hz. 13C NMR (75.5MHz, CDCl3): d 63.9 (C-
4), 65.0 (C-3), 65.1 (C-2), 114.8 (C-5), 128.2–133.5
(C6H5), 153.2 (C-6), 165.3, 165.5 (2BzCO), 185.9
(CHO). MS (FD) m/z 352 (M+). Anal. Calcd for
C20H16O6 (352.3): C, 57.39; H, 4.58. Found: C, 57.42;
H, 4.65.
C28H24O8 (488.5): C, 68.85; H, 4.95. Found: C, 69.09;
H, 5.02.
4.12. 2-(2-Benzoyloxyacetyl)furan 22
To a cooled (À5ꢁC) solution of endo-hydroxyfructal
ester 14 (400mg, 0.7mmol) in CH2Cl2 (20mL) was
added with stirring 0.15mL (3.5mmol) of dry methanol
followed by 0.1mL (0.85mmol) of SnCl4. The mixture
was then allowed to warm to room temperature. Con-
version of the educt was in favor of 17 (Rf 0.33, TLC
in 10:1 toluene/EtOAc) being reached within 1h. Dilu-
tion with CH2Cl2 (30mL), thorough washing with NaH-
CO3 solution (2 · 50mL) and brine (50mL), drying over
Na2SO4 of the organic phase, and evaporation to dry-
ness gave a residue, which was purified by elution from
a silica gel column (3 · 15cm) with 10:1 toluene/EtOAc.
Evaporation of the eluate to dryness and crystallization
of the residue from diethyl ether furnished 139mg (88%)
of 22 as colorless needles; mp 76–77ꢁC. 1H NMR
(300MHz, CDCl3): d 5.41 (s, 2H, BzOCH2), 6.58 (dd,
1H, H-4), 7.31 (dd, 1H, H-3), 7.44–8.15 (m, 5H,
C6H5), 7.63 (dd, 1H, H-5); J3,4 = 3.6, J3,5 = 0.6,
4.10. (3R,4S)-3,4-Bis(benzoyloxy)-6-(diethoxy)methyl-
3,4-dihydro-2H-pyran 20
Enal 19 (700mg, 2mmol) was dissolved in dry CHCl3
(5mL) and anhydrous EtOH (5mL) and the mixture
stirred for 4d at room temp. After completion of the
addition (monitoring by TLC in 20:1 toluene/EtOAc),
the solvents were removed in vacuo, and the residue
purified by elution from a silica gel column with 20:1 tol-
uene/EtOAc. Concentration of the appropriate eluate
furnished 660mg (78%) of 20 as a colorless syrup;
20
D
½a ¼ þ145:3 (c 1.0, CHCl3). 1H NMR (300MHz,
J4,5 = 1.7Hz. 13C NMR (75.5MHz, CDCl3):
d
CDCl3): d 1.25, 1.26 (two 3H-t, 2EtCH3), 3.63 (m, 4H,
2EtCH2), 4.32 (m, 2H, 2H2), 4.90 (s, 1H, CH(OEt)2),
5.40 (d, 1H, H-5), 5.56 (m, 1H, H-3), 5.88 (dd, 1H,
H-4, 7.30–8.00 (m, 10H, 2C6H5); J3,4 = 4.4,
J4,5 = 4.8Hz; MS (FD) m/z 426 (M+). Anal. Calcd for
C24H26O7 (426.4): C, 67.59; H, 6.14. Found: C, 67.46;
H, 6.04.
65.8 (BzOC), 112.5 (C-4), 117.9 (C-3), 128.5–133.4
(C6H5), 146.8 (C-5), 150.6 (C-2), 166.0 (BzCO), 181.6
(CO). MS (FI) m/z 230 (M+). Anal. Calcd for
C13H10O4 (230.2): C, 67.82; H, 4.38. Found: C, 67.63;
H, 4.37.
4.13. 2-(2-Hydroxyacetyl)furan 23
4.11. (2R,5S)-3,5-Bis(benzoyloxy)-2-(benzoyloxymethyl)-
2-methoxy-5,6-dihydro-2H-pyran 21
An aqueous solution of spirocyclic dihydropyranon 2529
(555mg, 3mmol, in 20mL) was refluxed in the presence
of 1mL of amberlite 120 (H+-form) for 1h, followed by
filtration, evaporation to dryness in vacuo, and purifica-
tion of the brownish residue by elution from a silica gel
column (2 · 30cm) with 25:1 CHCl3/MeOH). Removal
of the solvents left 23 (355mg, 93%), as colorless crystals
of mp 78ꢁC. Lit.:28 mp 78ꢁC.
To a solution of endo-hydroxyfructal ester 14 (520mg,
0.9mmol) in CH2Cl2 (20mL) was added dry methanol
(0.18mL, 4.4mmol) and freshly desiccated molecular
˚
sieves (4A), and the mixture cooled to 0ꢁC. BF3-ether-
ate (0.46mL, 3.9mmol) was then added dropwise in sev-
eral portions. The mixture was then stirred at ambient
temperature for 2days, after which TLC (10:1 toluene/
EtOAc), indicated the absence of educt. Quenching by
pouring into satd NaHCO3 solution (50mL), followed
by extraction with CH2Cl2 (3 · 30mL), and subjection
of the combined organic extracts to washing with 2M
HCl and water (2 · 20mL each), gave after drying over
Na2SO4 and concentration in vacuo, approximately a
5:1 mixture (1H NMR) of 16 and its 2-epimer (a-ano-
mer). Separation was effected on a silica gel column
(3.0 · 25cm) by elution with toluene/EtOAc (35:1).
The main eluate (Rf 0.30, TLC in 10:1 toluene/EtOAc)
afforded upon removal of the solvents in vacuo 320mg
4.14. (2R)-2-(Benzoyloxymethyl)-2-methoxy-2H-pyran-
3(6H)-one 24
˚
Molecular sieves (4A) and methanol (0.2mL) were
added to a CH2Cl2 solution of endo-hydroxyfructal ester
14 (390mg in 30mL), and after cooling to À10ꢁC, SnCl4
(0.20mL, 2.5molarequiv) was added in several portions
with stirring, which was continued for 1.5h at À10ꢁC.
The mixture was then poured into satd NaHCO3 solu-
tion and processed as described for 16. The eluate with
Rf 0.24 (TLC, 10:1 toluene/EtOAc) was evaporated to
dryness in vacuo. Trituration of the residue with diethyl
20
1
(74%) of syrupy 21; ½a ¼ À60:6 (c 1.0, CHCl3). H
ether resulted in crystallization of 24 (127mg, 72%) as
D
20
D
NMR (300MHz, CDCl3): d 3.48 (s, 3H, OCH3), 4.17
(ddd, 1H, H-6a), 4.37 (dd, 1H, H-6b), 4.63, 4.79 (two
1H-d, CH2OBz), 5.57 (ddd, 1H, H-5), 6.36 (dd, 1H,
H-4), 7.14–8.06 (m, 15H, 3C6H5); J4,5 = 6.1, J4,6b = 0.6,
colorless platelets of mp 106–108ꢁC; ½a ¼ À74:3 (c
1
1.1, CHCl3). H NMR (500MHz, CDCl3): d 3.50 (s,
3H, OCH3), 4.42 and 4.57 (two 1H-ddd, 6H2), 4.66,
4.75 (two 1H-d, CH2OBz), 6.18 (ddd, 1H, H-4), 7.07
(ddd, 1H, H-5), 7.4–8.0 (m, 5H, C6H5); J4,5 = 10.5,
J4,6 = 1.8 and 2.5, J5,6 = 1.9 and 3.8, J6,6 = 19.0,
J5,6 = 1.2 and 2.6, J6,6 = 12.9, JCH = 11.2Hz. 13C
2
NMR (75.5MHz, CDCl3): d 50.4 (OCH3), 62.8 (C-6),
63.5 (CH2OBz), 65.7 (C-5), 96.3 (C-2), 113.6 (C-4),
128.3–133.8 (C6H5), 148.8 (C-3), 163.3, 165.9, 166.1
(3BzCO). MS (FD) m/z 488 (M+). Anal. Calcd for
JCH = 11.4Hz. 13C NMR (75.5MHz, CDCl3): d 51.3
2
(OCH3), 60.7 (C-6), 62.4 (CH2OBz), 97.5 (C-2), 124.7
(C-4), 128.3–133.1 (C6H5), 147.7 (C-5), 165.9 (BzCO),